cancer, avastin - Yahoo Search Results

Ads
related to: cancer, avastin
New ENHERTU® Indication - Healthcare Professional Site

www.enhertuhcp.com
(fam-trastuzumab deruxtecan-nxki). Read The PI & Boxed Warnings on Physician Website. Learn About How ENHERTU® May Help Your Patients. Approved For a New Indication.
Common Adverse Reactions
Learn About Managing Potential

Adverse Reactions For ENHERTU®.

New Approval Info
ENHERTU® Is Now Approved For

a New Indication. Physician Site.

Efficacy Of ENHERTU®
Learn About The Efficacy

Of ENHERTU® For a New Indication.

Physician Resources
Access Physician Resources

For ENHERTU® On The Official Site.

Explore The Data
View More Information On

The Data & Results Of ENHERTU®.

About ENHERTU®
Discover If ENHERTU® May Be a

Treatment Option For Your Patients.
New ENHERTU® Indication - Information for Caregivers

www.enhertu.com
(fam-trastuzumab deruxtecan-nxki). Read The PI & Boxed Warnings on Patient Website. ENHERTU Is Now Approved For More Patients. Visit Site To Learn More.
Now FDA Approved · Understanding ENHERTU · Safety Information · Patient Information
Types: Potential Side Effects, Results with ENHERTU, ENHERTU Safety Info
ENHERTU® Information
ENHERTU® Safety Info
ENHERTU® Data
ENHERTU® Resources

Search results

- What This News Means for Merck
  Motley Fool· 2 years ago
  In combination with Roche's (OTC: RHHBY) bevacizumab (Avastin), Merck's (NYSE: MRK) oncology medicine -- co-owned with AstraZeneca (NASDAQ: AZN) and...
- Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
  Benzinga via Yahoo Finance· 1 year ago
  Genentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
- Pakistan probes distributors of Roche cancer drug after patients go blind
  Reuters via AOL· 9 months ago
  LAHORE, Pakistan (Reuters) -Pakistan said on Monday it was investigating two local distributors of...
- Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
  Zacks via Yahoo Finance· 1 year ago
  Roche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
- Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
  Zacks via Yahoo Finance· 1 year ago
  Roche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
- What Is Colorectal Cancer?
  Verywell Health via Yahoo News· 1 year ago
  Medically reviewed by Jay N. Yepuri, MD Colorectal cancer is the uncontrolled growth of cells in the colon or rectum. It’s the fourth most common type of...
- ImmunoGen (IMGN) Gets Accelerated FDA Approval for Ovarian Cancer Drug
  Zacks via Yahoo Finance· 2 years ago
  ImmunoGen (IMGN) receives accelerated FDA approval for its lead drug mirvetuximab soravtansine-gynx,...
- 15 Best Hospitals for Cancer Treatment in the US
  Insider Monkey via Yahoo Finance· 4 months ago
  In this article, we will be taking a look at the 15 best hospitals for cancer treatment in the US. If you are not interested in reading about the global...
- Ovarian cancer patient hails treatment as a 'lifeline'
  BBC via Yahoo News· 2 days ago
  A terminally ill woman who has lived longer than doctors predicted has said she has been given a lifeline thanks to a new treatment. Christine Campbell, from Dundonald was diagnosed with stage-four ...
- ImmunoGen's Newly Approved Ovarian Cancer Drug Listed As Preferred Regime
  Benzinga via Yahoo Finance· 1 year ago
  The National Comprehensive Cancer Network (NCCN) released new guidelines for ovarian cancer...